Titlebook: Recombinant Technology in Hemostasis and Thrombosis; Leon W. Hoyer,William N. Drohan Book 1991 Springer Science+Business Media New York 19

TEMPO

書目名稱Recombinant Technology in Hemostasis and Thrombosis影響因子(影響力)




書目名稱Recombinant Technology in Hemostasis and Thrombosis影響因子(影響力)學(xué)科排名




書目名稱Recombinant Technology in Hemostasis and Thrombosis網(wǎng)絡(luò)公開度




書目名稱Recombinant Technology in Hemostasis and Thrombosis網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Recombinant Technology in Hemostasis and Thrombosis被引頻次




書目名稱Recombinant Technology in Hemostasis and Thrombosis被引頻次學(xué)科排名




書目名稱Recombinant Technology in Hemostasis and Thrombosis年度引用




書目名稱Recombinant Technology in Hemostasis and Thrombosis年度引用學(xué)科排名




書目名稱Recombinant Technology in Hemostasis and Thrombosis讀者反饋




書目名稱Recombinant Technology in Hemostasis and Thrombosis讀者反饋學(xué)科排名

小溪

Molecular Defects in Hemophilia Brm whereas factor VIII is consumed. Marked genetic heterogeneity among different families with hemophilia B was suggested from comparison of factor IX antigen levels with clotting activities. In patients from different families, specific activities were usually distinctly different..

Myosin

Foam-Cells

Factor IX: Gene Structure and Protein Synthesis of the human factor IX gene, and discuss the various approaches to producing recombinant factor IX as a pharmaceutical. The molecular genetics of factor IX deficiency (hemophilia B) are discussed elsewhere in this book. The molecular biology and molecular genetics of blood coagulation have been reviewed recently..

沖突

Antithrombin III Genetics, Structure and Functionchiometric ATIII-enzyme complexes form as a result of interactions between the reactive site of ATIII and the active site of the protease target.. The rate of complex formation increases substantially in the presence of heparan sulfate proteoglycans on the surface of the vascular endothelium .,. or after addition of heparin . or pharmaceutically..

Herd-Immunity

出沒

thrombosis. The goal of the XXI Annual Scientific Symposium of the American Red Cross was to provide a forum to explore and document the impact of recombinant DNA technology in this field. The speakers described the essential features of the genes responsible for key plasma proteins important in he

彈藥

Biosynthesis and Assembly of the Factor VIII-Von Willebrand Factor Complexcofactor in the intrinsic coagulation pathway (1, 2) whereas vWF is hemostatically important in the mediation of platelet-vessel wall interactions at sites of vascular injury (3, 4). In blood, factor VIII and vWF are not present as distinct proteins but rather circulate as a linked complex. Several

饑荒

Factor IX: Gene Structure and Protein Synthesisques, DNA fragments can be cloned and characterized at the molecular level. This in turn led to the discovery of intervening sequences in some eukaryotic genes, the identification of promoter elements, and to the production of recombinant proteins. As with many other fields, the field of thrombosis

提名